Celldex Therapeutics shares owned by AQR Capital Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by AQR Capital Management
from 13F filings
Historical chart of AQR Capital Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by AQR Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $862k | 25k | 34.00 |
| 2024-06-30 | $291k | 7.9k | 37.01 |
| 2024-03-31 | $267k | 6.4k | 41.97 |
| 2023-06-30 | $232k | 6.8k | 33.93 |
| 2023-03-31 | $246k | 6.8k | 35.98 |
| 2022-12-31 | $382k | 8.6k | 44.57 |
| 2022-09-30 | $259k | 9.2k | 28.07 |
| 2022-06-30 | $255k | 9.5k | 26.96 |
| 2022-03-31 | $322k | 9.5k | 34.04 |
| 2021-12-31 | $366k | 9.5k | 38.69 |
| 2021-09-30 | $586k | 11k | 54.00 |
More positions owned by AQR Capital Management
Cigna Corp (CI)
View all positions for AQR Capital Management